Skip to main content

Peer Review reports

From: Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies

Original Submission
12 Jul 2019 Submitted Original manuscript
8 Jun 2020 Author responded Author comments - Gareth D James
27 Oct 2019 Reviewed Reviewer Report
27 Feb 2020 Reviewed Reviewer Report - Adrian P. Mander
13 Mar 2020 Reviewed Reviewer Report - Mark R Conaway
17 Mar 2020 Reviewed Reviewer Report
Resubmission - Version 2
8 Jun 2020 Submitted Manuscript version 2
29 Sep 2020 Author responded Author comments - Gareth D James
26 Jun 2020 Reviewed Reviewer Report
3 Aug 2020 Reviewed Reviewer Report
28 Aug 2020 Reviewed Reviewer Report - Research Square Reviewer 1
Resubmission - Version 3
29 Sep 2020 Submitted Manuscript version 3
26 Nov 2020 Author responded Author comments - Gareth D James
Resubmission - Version 4
26 Nov 2020 Submitted Manuscript version 4
Publishing
30 Nov 2020 Editorially accepted
5 Jan 2021 Article published 10.1186/s12885-020-07703-6

You can find further information about peer review here.

Back to article page